Search Results - sumati+(sumi)+rajagopalan

2 Results Sort By:
Therapeutic Methods Based on In Vivo Modulation of the Production of Interferon gamma
The technology offered for licensing is in the field of Therapeutics. More specifically, the technology relates to biological ligands and their use as modulators of the production of Interferon gamma as a means to treat a broad spectrum of diseases. The invention describes and claims antibodies and other ligands that can stimulate Natural Killer (NK)...
Published: 10/28/2024   |   Inventor(s): Sumati (Sumi) Rajagopalan, Eric Long
Keywords(s): Against, antibodies, DB3XXX, DB4XXX, DBXXXX, DC1XXX, DCXXXX, Directed, DXXXXX, Gamma, INTERFERON, KIR2DL4, LIGANDS, Patent Category - Biotechnology, production, RECEPTOR
Category(s): Collaboration Sought > Licensing, Application > Therapeutics, TherapeuticArea > Infectious Disease, Application > Vaccines
Late First-Row Transition Metal Hydrogenation and Hydrosilylation Catalysts
The processes of Hydrosilylation or Hydrogenation are widely used in the manufacturing of silicone-based materials and as a precursor in pharmaceuticals. These materials include coatings, adhesives, sealants, and cured rubbers. These processes rely on the use of metal catalysts. Unfortunately, these catalysts are relatively toxic, rare, and are very...
Published: 2/23/2023   |   Inventor(s): Ryan Trovitch, Tufan Mukhopadhyay, Raja Pal, Hagit Ben-Daat, Tyler Porter
Keywords(s): Catalysis, Materials and Electronics, Mechanical and Manufacturing
Category(s): Advanced Materials/Nanotechnology